Products

Galen
Ibex Medical Analytics
Oncology AI
Galen, by Ibex Medical Analytics, is an FDA-cleared AI-powered pathology platform that assists pathologists in detecting cancer and other diagnostic features in multiple tissue types, enhancing diagnostic accuracy and efficiency.
Galen™ Second Read™
Ibex Medical Analytics
Oncology AI
Galen™ Second Read™ (now Ibex Prostate Detect in the US) is an AI-powered digital pathology solution by Ibex Medical Analytics that analyzes prostate core needle biopsies to detect potentially missed cancers, providing pathologists with alerts and heatmaps to enhance diagnostic accuracy and streamline workflows.

See all 2 products →

About Ibex Medical Analytics

Ibex Medical Analytics is a pioneering healthcare AI company that develops and deploys clinical-grade artificial intelligence solutions to transform cancer diagnostics in pathology. Their flagship Galen™ platform leverages advanced AI, data science, image analysis, and machine learning technologies applied to digitized glass slides and electronic medical records. This platform is designed to assist pathologists in their routine clinical workflows, enhancing diagnostic accuracy, streamlining laboratory operations, and reducing turnaround times for critical diagnoses.

For physicians, Ibex’s solutions provide crucial decision support tools, enabling more objective, accurate, and rapid identification and grading of various cancers, including breast, prostate, and gastric. The platform acts as a comprehensive quality control mechanism, detecting small foci of cancer and higher-grade malignancies that might otherwise be missed, thereby improving patient safety and diagnostic confidence. Furthermore, Ibex is actively expanding its capabilities into the biopharma sector, supporting biomarker discovery, optimizing clinical trial efficiency, and generating companion diagnostic (CDx)-ready evidence to accelerate drug development and advance precision oncology.

Ibex’s commitment to a “by pathologists, for pathologists” approach ensures their technology is a collaborative assistant, deeply integrated into existing lab systems to provide actionable insights and improve overall patient outcomes. The company’s solutions are widely deployed globally, demonstrating real-world clinical impact and contributing to a global shift towards AI-powered pathology as a new standard for cancer detection.

Focus Areas

AI-powered cancer diagnostics digital pathology breast cancer prostate cancer gastric cancer biomarker discovery clinical trial efficiency CDx-ready evidence generation image analysis machine learning deep learning quality control workflow optimization

Business Intelligence

Key Investors83North, Sienna Venture Capital, Octopus Ventures, aMoon, Planven Entrepreneur Ventures, Dell Technologies Capital, NewHealth Ventures, Kreos Capital, BeyondBio (Israel)
PartnershipsCorePlus Servicios Clínicos y Patológicos, HNL Lab Medicine, Philips, Institut Curie, PathGroup, Fimlab, FUJIFILM Healthcare Europe, Quest Diagnostics, Proscia, Roche, Alverno Laboratories, AstraZeneca, Daiichi Sankyo
Acquisitionsnone
TechnologyAI-powered pathology platform (formerly GALEN) built on Deep Learning algorithms, computer vision-based image analysis, and machine learning technologies. Supports cloud-native, on-prem, hybrid, or air-gapped environments and is compatible with WSI scanners, DICOM-DP infrastructure, and HL7/FHIR workflows.
FDA Clearances1 cleared products (estimated)

Products by Ibex Medical Analytics

2 products in the directory

Galen
Ibex Medical Analytics
Oncology AI
Galen, by Ibex Medical Analytics, is an FDA-cleared AI-powered pathology platform that assists pathologists in detecting cancer and other diagnostic features in multiple tissue types, enhancing diagnostic accuracy and efficiency.
Galen™ Second Read™
Ibex Medical Analytics
Oncology AI
Galen™ Second Read™ (now Ibex Prostate Detect in the US) is an AI-powered digital pathology solution by Ibex Medical Analytics that analyzes prostate core needle biopsies to detect potentially missed cancers, providing pathologists with alerts and heatmaps to enhance diagnostic accuracy and streamline workflows.

What the Web Says

Ibex Medical Analytics is a company that develops AI-powered cancer diagnostics for pathology labs. Their flagship product, the Galenu2122 platform, aims to enhance diagnostic accuracy and efficiency for pathologists. While product reviews are generally positive, highlighting improved accuracy and workflow, employer reviews for a company named 'Ibex' (which appears to be a call center operation and not Ibex Medical Analytics) on platforms like Reddit and Indeed are overwhelmingly negative, citing poor working conditions and management.

Overall: Mixed

Strengths

  • Enhanced diagnostic accuracy and reduced errors in cancer detection and grading.
  • Increased efficiency and productivity for pathologists by automating tasks and prioritizing cases.
  • Provides a crucial patient safety net through automated 'second reads' and 100% quality control.
  • Integrates with existing pathology workflows and systems.
  • Knowledgeable staff and timely support responses.
  • Positive impact on diagnostic quality, pathologist satisfaction, and patient outcomes.

Limitations

  • High initial investment required for implementing digital pathology and AI infrastructure.
  • Integration with legacy lab systems can be complex and resource-intensive.
  • Pricing is customized and not publicly listed, potentially making it cost-prohibitive for some institutions.
  • Regulatory hurdles may limit specific uses in certain regions.
  • Some Reddit and Indeed reviews for a company named 'Ibex' (likely a call center) describe a terrible working environment, micromanagement, and lack of transparency, though these do not appear to be related to Ibex Medical Analytics.

Based on reviews from: Skywork, Ibex Medical Analytics Galen AI Pathology 2023 Report, Israeli startup Ibex Medical aims to transform cancer diagnostics with AI tech, The Lancet Reports Outstanding Performance of Ibex Medical Analytics' AI-based Algorithm in a Study at UPMC, DigitalHealth.London, Ibex Medical Analytics Website, PR Newswire, Reddit, Indeed.com, G2, Capterra

Last updated: 2026-07-18

Videos

News, demos, and interviews about Ibex Medical Analytics.

Loading videos...

Videos load interactively. If none appear, search YouTube for Ibex Medical Analytics →

View all on YouTube

Press & Coverage

Ibex Medical Analytics Press Release
Ibex Medical Analytics Unveils Ibex 4, the Next-Generation AI Platform Setting a New Standard in Comprehensive Cancer Diagnostics and Patient Care
Ibex Medical Analytics launched Ibex 4, its next-generation AI platform, featuring an enhanced user experience and an end-to-end breast workflow with automated H&E analysis and 'zero-click' IHC quantification for more efficient and accurate scoring of HER2, ER, PR, and Ki67.
2026-03
Business Wire
Ibex Medical Analytics Establishes Biopharma Advisory Board to Advance AI-Powered Precision Diagnostics
Ibex Medical Analytics announced the formation of its Biopharma Advisory Board, appointing Dr. Ruth March and Dr. Paolo Tarantino as its first members to provide strategic and scientific guidance for expanding its Biopharma Services.
2026-05
Ibex Medical Analytics Press Release
Ibex Medical Analytics and mTuitive Announce Strategic Partnership to Transform Digital Pathology with AI-Enhanced Structured Reporting
Ibex Medical Analytics and mTuitive, Inc. partnered to deliver an integrated AI-enhanced structured reporting workflow, combining Ibex's pathology algorithms with mTuitive's CAP-, RCPath-, and ICCR-compliant synoptic reporting platform.
2026-03
Ibex Medical Analytics Press Release
Ibex Medical Analytics Announces Expansion of its Biopharma Business, Extending AI Pathology Platform into Early Biomarker Development
Ibex Medical Analytics expanded its biopharma business to extend its AI pathology platform into earlier translational research, biomarker development, and trial-efficiency optimization.
2026-01
Targeted Oncology
FDA Grants 510(k) Clearance to Ibex Prostate Detect AI for Prostate Cancer
The FDA granted 510(k) clearance to Ibex Prostate Detect software, an AI-powered digital pathology solution that assists in identifying small and rare prostatic cancers via tissue biopsies, marking Ibex Medical Analytics' first regulatory clearance.
2025-02
Ibex Medical Analytics Press Release
AI-Driven Accuracy and Efficiency in Breast Cancer Diagnosis: New Study Validates Ibex Breast Solution
A peer-reviewed study published in Clinical Breast Cancer confirmed that Ibex Breast, an AI-powered diagnostic support solution, significantly improves accuracy and efficiency in evaluating breast pathology cases, boosting diagnostic accuracy to 100% and reducing review time by up to 23%.
2025-05
Ibex Medical Analytics Press Release
International multi-site study of Ibex Medical Analyticsu2019 AI-powered solution demonstrates improved HER2 biomarker scoring in breast cancer
An international multi-site study published in JCO Precision Oncology demonstrated that Ibex Breast HER2, an AI-powered solution, improves HER2 biomarker scoring accuracy and consistency in breast cancer diagnosis.
2024-10
Ibex Medical Analytics Press Release
Ibex Raises $55 Million in Series C Funding to Drive Global Adoption of AI for Cancer Diagnosis
Ibex Medical Analytics closed a $55 million Series C financing round led by 83North, bringing its total funding to over $100 million since its inception in 2016, to expand its footprint in the United States and accelerate product portfolio growth.
2023-09

Frequently Asked Questions

Ibex's Galenu2122 platform integrates into digital pathology workflows by analyzing whole slide images using AI, data science, image analysis, machine learning, and deep learning technologies. It provides pathologists with diagnostic insights, such as cancer heatmaps, grading, and measurements, to enhance accuracy, implement quality control, and optimize workflows by pre-screening cases or pre-ordering IHCs.
Clinical studies demonstrate high accuracy for Ibex's solutions, with Ibex Prostate Detect showing a 99.6% positive predictive value for cancer heatmap accuracy and identifying 13% of missed cancers in a study. Ibex Breast improved diagnostic accuracy to 100% in a study, reducing review time and IHC orders, while Galen Breast reduced major discrepancy rates by 29%. The platform provides comprehensive quality control by acting as a safety net, alerting pathologists to suspicious regions and ensuring no suspicious lesion is overlooked.
Ibex's platform supports biomarker discovery, clinical trial efficiency, and CDx-ready evidence generation, backed by an ISO 13485-compliant Quality Management System. They are expanding into earlier translational research and biomarker development, offering new AI modules for HER2 Low & HER2-Ultra-Low quantification and tumor microenvironment analysis. This aims to accelerate drug development pipelines and improve evidence quality worldwide.
Ibex Prostate Detect has received FDA 510(k) clearance in the U.S. Multiple Ibex solutions, including those for prostate, breast, and gastric cancer, as well as HER2 biomarker scoring, are CE-IVD certified under the IVDR framework. The company also holds quality and security certifications such as HITRUST, Cyber Essentials Plus, ISO 27001, and ISO 13485.
Implementing Ibex's AI solutions involves integrating them with existing digital pathology infrastructure, including image management systems (IMS), whole slide imaging (WSI) scanners, and Laboratory Information Systems (LIS). Ibex partners with leading providers to ensure secure, flexible, and interoperable workflows. Pricing for Ibex Medical Analytics' enterprise-level software is customized per institution, depending on factors like specific modules, annual case volume, and integration complexity, and is not publicly listed.
Ibex has strategic partnerships with leading digital pathology vendors like Proscia and Indica Labs for integration, and with major healthcare providers such as Quest Diagnostics, HNL Lab Medicine, PathGroup, and Institut Curie for clinical deployment and validation. They also collaborate with biopharma companies like AstraZeneca and Daiichi Sankyo for biomarker development. These partnerships, along with over $114M in funding and a growing global customer base, underscore Ibex's stability and leadership in AI-powered pathology.

Investors

Who's funded Ibex Medical Analytics.

Related Companies

Intelligent Voice AI (IVAI) is an agentic AI platform that deploys AI voice agents specifically designed for healthcare, insurance, legal, and home services businesses. For physicians and medical practices, IVAI’s Evolve AI Agents act as an AI workforce, not just an answering service, handling a comprehensive range of administrative and operational tasks. These agents can […]

Dext, formerly known as Receipt Bank, is a company that specializes in bookkeeping automation, leveraging data, technology, and applied AI to enhance productivity and efficiency for businesses, accountants, and bookkeepers. [3, 16] Their platform is designed to streamline financial document management and automate bookkeeping tasks, aiming to simplify the accounting process and enable more informed […]

Cortex (https://www.cortex.app) is an AI-powered internal developer portal designed to enhance engineering excellence and streamline software development workflows. For physicians, this translates to a platform that can indirectly improve healthcare technology by enabling engineering teams to build more reliable, secure, and efficient software. The platform helps in cataloging, scoring, and assigning actions to improve service […]

Nino is an AI-powered financial planning and tax service that aims to provide comprehensive financial guidance. For physicians, Nino’s AI software can help manage income, student loans, and plan career transitions, such as moving from training to practice or considering practice ownership. The platform allows physicians to view loans, income, and savings in one place, […]

Coral AI is a healthcare artificial intelligence company that aims to streamline administrative workflows for healthcare providers, ultimately accelerating patient access to care. The company’s AI-driven platform integrates with existing healthcare systems, including EHRs, fax lines, and payer portals, to automate complex administrative tasks. This includes patient intake, prior authorizations, billing, compliance, and patient outreach. […]

SamaCare is a healthcare AI company that provides a cloud-based workflow intelligence platform designed to streamline the prior authorization process for specialty medications. The company’s platform aims to reduce the administrative burden on medical practices, improve approval rates, and add predictability to patient care. By digitizing the often manual and paper-heavy prior authorization process, SamaCare […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.